Covetrus posts smaller Q4 loss on flat sales, sees 2022 growth

Covetrus Inc. (Nasdaq: CVET), the Portland-based animal health technology and services company, posted a smaller fourth-quarter loss in 2021 than a year ago, and forecast higher sales growth for 2022.

The company late Thursday reported a before-tax loss of $10 million, or 2 cents per share, for the three months ended Dec. 31, 2021. That was down from a loss of $16 million, or 4 cents per share, for the same period in 2020.

Net sales for the fourth quarter of 2021 were $1.12 billion, unchanged compared to the year-ago quarter. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025